title: Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells.
abstract: Galectins are members of a family of beta-galactosides-binding proteins that have recently emerged as novel modulators in different aspects of cancer. The expression of galectins in tumors and/or the tissue surrounding them has been well documented. Since galectin-7 expression has been associated with epithelial tissues and varies significantly in various types of cancer, we have investigated for the first time its role in breast cancer. Using two preclinical mouse models, high levels of galectin-7 expression in breast cancer cells drastically increased their ability to metastasize to lungs and bones. Significant increases in the number of pulmonary metastases and osteolytic lesions were induced by overexpression of galectin-7 compared with control cells. In human tissues, galectin-7 was specifically found in myoepithelial cells of normal human breast tissue, but not in luminal cells. Its expression was severely altered in breast carcinoma, many samples showing greater than 70% of galectin-7 positive cells. High expression levels of galectin-7 were restricted to high-grade breast carcinomas, including HER2 overexpressing and basal-like groups. In HER2 overexpressing cases, galectin-7 expression was associated with lymph node axillary metastasis. Taken together, our results indicate that galectin-7 may represent a potential target for both specific detection and therapeutic inhibition of metastatic breast cancer.
authors.affiliation: Institut national de la recherche scientifique-Institut Armand-Frappier, Laval, Québec, Canada, H7V 1B7.
authors.forename: Mélanie
authors.initials: M
authors.lastname: Demers
authors.forename: April A N
authors.initials: AA
authors.lastname: Rose
authors.forename: Andrée-Anne
authors.initials: AA
authors.lastname: Grosset
authors.forename: Katherine
authors.initials: K
authors.lastname: Biron-Pain
authors.forename: Louis
authors.initials: L
authors.lastname: Gaboury
authors.forename: Peter M
authors.initials: PM
authors.lastname: Siegel
authors.forename: Yves
authors.initials: Y
authors.lastname: St-Pierre
mesh_terms: D000328:Adult; D000818:Animals; D015415:Biomarkers / Q000378:metabolism*; D001859:Bone Neoplasms / Q000556:secondary; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology*; D004847:Epithelial Cells / Q000378:metabolism*; D005260:Female; D037161:Galectins / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary; D008321:Mammary Glands, Animal / Q000166:cytology / Q000378:metabolism / Q000473:pathology; D042361:Mammary Glands, Human / Q000166:cytology / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000473:pathology; D014407:Tumor Cells, Cultured
chemical_list: D015415:Biomarkers; D037161:Galectins; C092525:LGALS7 protein, human; C490487:Lgals7 protein, mouse
references.citation: Cancer Res. 2004 May 1;64(9):3037-45
references.pmid: 15126339
references.citation: Cell Mol Life Sci. 2007 Jul;64(13):1679-700
references.pmid: 17497244
references.citation: Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11329-34
references.pmid: 10500176
references.citation: Cancer Cell. 2008 Feb;13(2):141-52
references.pmid: 18242514
references.citation: Mol Cancer Res. 2007 Oct;5(10):1001-14
references.pmid: 17951401
references.citation: Nat Rev Cancer. 2002 Aug;2(8):584-93
references.pmid: 12154351
references.citation: Biochem Biophys Res Commun. 2009 Feb 6;379(2):626-31
references.pmid: 19124005
references.citation: Mol Cancer Res. 2005 Jan;3(1):1-13
references.pmid: 15671244
references.citation: Dev Biol. 1995 Apr;168(2):259-71
references.pmid: 7729568
references.citation: Nat Genet. 2002 Dec;32 Suppl:533-40
references.pmid: 12454650
references.citation: Nature. 2000 Aug 17;406(6797):747-52
references.pmid: 10963602
references.citation: Apoptosis. 2005 Mar;10(2):267-75
references.pmid: 15843888
references.citation: Mol Biol Cell. 2008 Dec;19(12):5541-9
references.pmid: 18829868
references.citation: Nature. 1994 May 26;369(6478):321-3
references.pmid: 8183370
references.citation: Mol Cancer. 2008 Jun 04;7:49
references.pmid: 18533032
references.citation: Nature. 1997 Sep 18;389(6648):300-5
references.pmid: 9305847
references.citation: Cancer Res. 1997 Dec 1;57(23):5272-6
references.pmid: 9393748
references.citation: J Biol Chem. 2002 Feb 1;277(5):3487-97
references.pmid: 11706006
references.citation: Cancer Res. 2005 Jun 15;65(12):5205-10
references.pmid: 15958565
references.citation: Histopathology. 1991 Nov;19(5):403-10
references.pmid: 1757079
references.citation: Clin Cancer Res. 2005 Mar 1;11(5):1918-27
references.pmid: 15756018
references.citation: Cancer Cell. 2003 Jun;3(6):537-49
references.pmid: 12842083
references.citation: Glycoconj J. 2004;19(7-9):441-9
references.pmid: 14758067
references.citation: J Biol Chem. 2002 May 3;277(18):15819-27
references.pmid: 11839755
references.citation: Cancer Res. 2004 Aug 15;64(16):5672-6
references.pmid: 15313906
references.citation: Mod Pathol. 2002 Dec;15(12):1294-301
references.pmid: 12481010
references.citation: Cancer Res. 1992 Mar 15;52(6):1399-405
references.pmid: 1540948
references.citation: Cancer Res. 2007 Mar 15;67(6):2824-9
references.pmid: 17363605
references.citation: Nat Rev Cancer. 2005 Jan;5(1):29-41
references.pmid: 15630413
references.citation: J Pathol. 1996 May;179(1):43-8
references.pmid: 8691344
references.citation: J Biol Chem. 1995 Mar 17;270(11):5823-9
references.pmid: 7534301
references.citation: Mol Carcinog. 1997 Oct;20(2):204-15
references.pmid: 9364210
references.citation: Biochem Biophys Res Commun. 2009 Sep 25;387(3):425-9
references.pmid: 19596268
references.citation: Oncogene. 2003 Sep 18;22(40):6277-88
references.pmid: 13679866